Skip to main content
Call 24/7: 1-800-400-1805
1-800-400-1805 Free Case Review
Sign In Join Free

what are meso settlements actually averaging these days

Patient · · 61 views
So I'm trying to get a realistic picture of what a stage 2 peritoneal case might be worth before I commit to treatment and legal stuff. I know every case is different but I'm seeing all these vague ranges online and it's not helpful.

From what I've gathered, the ranges are all over the place depending on stage, cell type, work history, and whether it goes to trial versus settlement. I worked at Johns-Manville in Cleveland from 1978 to 1985 in insulation manufacturing, so there's clear exposure documentation and the company's still solvent which I guess matters.

I've read that settlements can range anywhere from 1 million to over 2 million for peritoneal cases, but I'm not finding specifics on what stage 2 typically settles for. Also not clear on whether having better prognosis (which I'm hoping is the case) helps or hurts the settlement value, since you'd theoretically live longer to deal with the disease.

Has anyone here actually gone through settlement and are you willing to share ballpark figures? I'm not asking for exact amounts, just trying to understand if I should be thinking in the 1 million range or if that's way off. My attorney has been vague about timelines and amounts so far.

11 Replies

Family
I'm coming at this from a different angle than you since my dad's case is pleural, not peritoneal, but I can tell you what we've learned navigating this. The vagueness from attorneys is real and honestly it drove me crazy at first. They do it because every single case genuinely is different, and I say that as someone who reads medical literature for work.

What I noticed with my dad's situation is that having documentation of exposure at a major manufacturer like Johns-Manville actually matters way more than stage at settlement time. The company's solvency and your employment dates are what your legal team will focus on first. Stage 2 peritoneal with clear work history is actually a stronger position than you might think, even if prognosis is better. Better prognosis doesn't hurt you the way you're worried about, it just means the calculation includes more years of ongoing treatment costs and quality of life impact. We got a detailed breakdown from an economist in October 2025 that itemized everything from chemotherapy protocols to palliative care, and that's what actually drove the numbers.

The 1 to 2 million range for peritoneal is in the ballpark but honestly it depends hard on whether you're looking at pre-trial settlement versus structured settlement versus actual litigation. And I'd push back on your attorney being vague. You have the right to ask them specifically what comps they're looking at for stage 2 peritoneal cases with documented asbestos exposure from manufacturing. They should have actual case files to reference, not just ranges.

One thing nobody tells you: get a second opinion from a different firm. We did that at the end of August and it completely changed what we understood about settlement timing.
Medical ✓ Expert Response
Not going to give you settlement figures because that's genuinely outside what I can speak to as a clinician, but I can address the prognosis question you raised because I think it's actually backwards from what you're assuming.

Better prognosis in peritoneal mesothelioma doesn't hurt your case, at least not from what patients have told me over the years. Stage 2 peritoneal with epithelioid cell type (the more favorable kind) tends to respond well to cytoreductive surgery combined with HIPEC (heated chemotherapy delivered directly into the abdomen during surgery). The 2019 Sugarbaker data out of Washington Hospital Center showed five-year survival rates approaching 40-50% for selected peritoneal patients, which is dramatically different from pleural meso numbers most people have heard.

So here's what I'd actually focus on right now. Your stage and cell type matter enormously for treatment planning and that information also matters for your legal team. Get a pathology report that specifies epithelioid, sarcomatoid, or biphasic. If nobody has said that word to you yet, ask.

The Johns-Manville exposure history you described, 1978 to 1985 in insulation manufacturing in Cleveland, that's well documented territory from a medical causation standpoint. Clear occupational exposure with a company that has established trust funds is a different situation than cases with disputed exposure.

Please make sure you're talking to your oncologist specifically about HIPEC candidacy before anything else. That conversation could change the entire picture.
3 found this helpful
Patient
I really appreciate you clarifying that about prognosis because my attorney kind of danced around it and honestly I wasn't sure if living longer was going to work against me financially. So if I'm understanding right, stage 2 epithelioid actually puts me in a better position both medically and legally, which is... kind of a relief to hear. Do you see a lot of peritoneal patients at your clinic choosing HIPEC, and if so, do you have a sense of how it affects their outcomes compared to just chemo alone?
Medical ✓ Expert Response
Not my area of specialty as an oncologist, but I've sat with enough patients going through this simultaneously that I can share a few things I've observed.

On the prognosis question, yes, better survival outlook can actually complicate settlement value in ways that feel counterintuitive. A stage 2 peritoneal case with epithelioid cell type (the most common and most treatment-responsive subtype) may settle differently than a later-stage case precisely because plaintiffs are expected to live longer and incur ongoing medical costs. I've seen this genuinely cut both ways depending on how the legal team frames future medical expenses.

The Johns-Manville exposure window you're describing, 1978 to 1985 in Cleveland, is the kind of documented occupational history that attorneys can build a strong causation argument around. That company's bankruptcy trust is one of the more established ones. Your attorney should be specific with you about whether they're pursuing trust claims, litigation, or both, because the timelines and amounts differ significantly.

One thing I've watched patients struggle with is sequencing treatment and legal decisions as if they're separate tracks. They're not, really. The Peritoneal Surface Oncology Group International published data in 2021 showing median survival for stage 2 epithelioid peritoneal mesothelioma with cytoreductive surgery plus HIPEC (heated chemotherapy delivered directly into the abdomen) can exceed 5 years. That prognosis data will matter to whoever is calculating your case value.

Please do talk to your oncologist about staging confirmation and cell type before any of this gets too far along. It changes the picture on both sides of what you're weighing.
3 found this helpful
Patient
Yeah I get it, the vagueness drives you nuts. I'm pleural not peritoneal but the settlement stuff is kinda similar from what I've learned.

My lawyer was also doing the "every case is different" dance for like three months before I finally pushed back and said look, just give me a ballpark so I can plan. Turns out he was being cautious because my case was still pretty fresh, February 2026 when I had the EPP, and apparently they like to wait til you're further out to see how you're actually doing health-wise. That matters more than people think. Better prognosis can go either way like you said but honestly from what I've heard it's less about how long you'll live and more about what you spent to get treatment and what your actual lost wages were.

The Johns-Manville exposure is huge tho. That's documented institutional knowledge they can't wiggle out of. Clear paper trail beats "I think I worked around some stuff in the 80s" every single time.

I won't throw numbers around because honestly every case really is different and I don't want to mess with your head, but I will say don't let your lawyer stay vague forever. Push back. Ask them specifically what stage 2 peritoneal cases in your region have settled for in the last couple years. They might not give exact figures but they can give you a range and a timeline. If they still won't after you ask twice, that's kinda a red flag.

How far along are you in treatment planning right now?
Patient
That's really helpful to know about the timing thing. So your lawyer wanted to see how you recovered from the EPP before throwing out numbers, which I guess makes sense even though it's frustrating. Did he eventually give you a range once you were further out, or is he still being cagey? I'm asking because I'm trying to figure out if I should push harder on this now before I decide whether to do the HIPEC surgery, or if there's actually a benefit to waiting til after treatment to have those conversations.
Veteran
I'm pleural not peritoneal so take that into account, but I'll tell you what I know. Got diagnosed June of this year, had the surgery August 15th. My attorney at the VA told me straight up that peritoneal cases tend to settle higher than pleural because of the prognosis difference, but that's backwards from what you're thinking. Longer life expectancy actually means higher settlement because you're looking at more medical costs down the road, more lost wages if you can't work, pain and suffering over a longer timeline. That's the logic anyway.

The Johns-Manville exposure is solid documentation. That matters. My shipboard records from the Oriskany were enough to get me in the VA system quick, but you've got a company that's still operating and can actually pay, which is different than what a lot of us deal with.

One thing nobody tells you upfront is the legal fees eat a chunk. My attorney made it clear that's coming out before I see anything. Also the timeline thing your attorney is being vague about, that's normal. These things don't move fast. I'm four months post-op and we're still in early discovery phase.

Don't make treatment decisions based on settlement numbers. Get the treatment you need regardless. I decided on the surgery because my oncologist said it gave me the best shot, not because of what the case might be worth. The settlement becomes secondary once you're dealing with the actual disease.

Push your attorney for more specifics though. If they won't talk numbers after initial consultation, that's worth noting.
Medical ✓ Expert Response
What you're feeling right now, that need to get a concrete number so you can actually plan, makes complete sense. The vagueness is genuinely hard to sit with when you're trying to make real decisions.

I can share what I've seen in 12 years working with mesothelioma patients. Peritoneal cases with clear exposure documentation like yours tend to settle higher than pleural in many situations, partly because peritoneal patients often have longer survival windows and can demonstrate ongoing damages more concretely. Your Johns-Manville documentation from that specific period is actually significant because exposure records from that era are well-preserved and liability is well-established.

The prognosis question you raised is one I hear a lot and it's complicated. A better prognosis doesn't necessarily hurt value, because courts and defendants factor in future medical costs, lost quality of life, and ongoing treatment expenses. Stage 2 with good prognosis can still carry substantial value for exactly those reasons.

What I've watched happen with clients is that the attorneys who specialize specifically in asbestos litigation, not general personal injury, tend to give clearer projections earlier in the process. If your current attorney is still being vague after you've shared your work history details, it might be worth a second consultation just to compare.

I'd also gently say, and I mean this from a clinical standpoint, trying to make treatment decisions contingent on settlement figures can put you in a really painful holding pattern. The two processes can run parallel. Talking with an oncology social worker at your treatment center about this specific anxiety, the uncertainty of it all, might help more than you'd expect.
3 found this helpful
Patient
Thanks Amy, that's actually helpful context. So if peritoneal cases settle higher partly because of longer survival, does that mean my stage 2 diagnosis could actually work in my favor compared to someone diagnosed at stage 3 or 4? I've been worried the opposite was true. And when you say "clear exposure documentation" matters, I'm assuming Johns-Manville records plus my own employment history counts, but have you seen cases where that documentation made a significant difference in the final number?
Medical ✓ Expert Response
What you're feeling right now makes complete sense. Trying to get a realistic picture before committing to treatment and legal decisions at the same time is genuinely exhausting, and the vagueness you're running into is real, not just you missing something.

I've worked with peritoneal patients for over a decade and the honest truth is the variation in settlement amounts even within stage 2 cases is significant enough that ranges kind of lose meaning. But your situation has some factors that tend to work in your favor. Clear employer documentation, a solvent defendant, and a specific exposure window like yours (1978 to 1985 at a named facility) are things attorneys consider meaningful. Peritoneal cases with epithelioid cell type also tend to settle differently than sarcomatoid, so if you know your pathology that's worth discussing.

On the prognosis question, you're actually thinking about it correctly. Better prognosis with peritoneal can genuinely cut both ways in valuation and your attorney should be talking you through that honestly. If they're still being vague after you've asked directly, a second opinion consultation with another mesothelioma attorney costs nothing and can give you a comparison point. I had a client in 2019 who did exactly that and the second firm's assessment was substantially more detailed on exactly this question.

Journaling the specific questions you need answered before each attorney call can help you feel less at the mercy of the process. And if the stress of all of this is becoming hard to carry alone, please reach out to a counselor who specializes in oncology. This is a lot to hold.
2 found this helpful
Patient
I appreciate you jumping in on this. The part about variation within stage 2 cases really does help because at least it explains why my attorney keeps dodging specifics. What factors have you seen make the biggest difference in outcomes for peritoneal cases specifically? I'm wondering if cell type matters as much as the exposure documentation, or if they weight them equally.

Share Your Experience

Sign in or create a free account to share your experience.

Sign In Create Account

Discussions in this community are for informational and emotional support purposes only. They do not constitute legal advice, medical advice, or an attorney-client relationship. Always consult a qualified professional for advice specific to your situation. Community Guidelines

Call Now: (800) 400-1805 Free Case Review • Available 24/7